Literature DB >> 23613078

Risks of in utero exposure to valproate.

Kimford J Meador, David W Loring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23613078      PMCID： PMC3685023          DOI： 10.1001/jama.2013.4001

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  Valproate prescription prevalence among women of childbearing age.

Authors:  Katherine L Wisner; Emily Leckman-Westin; Molly Finnerty; Susan M Essock
Journal:  Psychiatr Serv       Date:  2011-02       Impact factor: 3.084

2.  Autism spectrum disorders following in utero exposure to antiepileptic drugs.

Authors:  R L Bromley; G Mawer; J Clayton-Smith; G A Baker
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

3.  Valproate: a new cause of birth defects--report from Italy and follow-up from France.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1983-08-26       Impact factor: 17.586

4.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

Review 5.  Valproic acid monotherapy in pregnancy and major congenital malformations.

Authors:  Janneke Jentink; Maria A Loane; Helen Dolk; Ingeborg Barisic; Ester Garne; Joan K Morris; Lolkje T W de Jong-van den Berg
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  Characteristics of fetal anticonvulsant syndrome associated autistic disorder.

Authors:  A D Rasalam; H Hailey; J H G Williams; S J Moore; P D Turnpenny; D J Lloyd; J C S Dean
Journal:  Dev Med Child Neurol       Date:  2005-08       Impact factor: 5.449

Review 7.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

8.  The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.

Authors:  Rebecca Louise Bromley; George E Mawer; Maria Briggs; Christopher Cheyne; Jill Clayton-Smith; Marta García-Fiñana; Rachel Kneen; Sam B Lucas; Rebekah Shallcross; Gus A Baker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-31       Impact factor: 10.154

Review 9.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; K J Meador; P B Pennell; W A Hauser; G S Gronseth; J A French; S Wiebe; D Thurman; B S Koppel; P W Kaplan; J N Robinson; J Hopp; T Y Ting; B Gidal; C A Hovinga; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; D Hirtz; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

10.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245
View more
  7 in total

1.  Women with epilepsy planning pregnancy: we can improve outcomes by improving care.

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2013-09       Impact factor: 7.500

2.  Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex.

Authors:  C T Engineer; T M Centanni; K W Im; M S Borland; N A Moreno; R S Carraway; L G Wilson; M P Kilgard
Journal:  Dev Neurobiol       Date:  2014-04-04       Impact factor: 3.964

3.  Surgery for infants with catastrophic epilepsy: an analysis of complications and efficacy.

Authors:  Ramesh M Kumar; Susan Koh; Kelly Knupp; Michael H Handler; Brent R O'Neill
Journal:  Childs Nerv Syst       Date:  2015-05-29       Impact factor: 1.475

4.  The need for safer medication use in pregnancy.

Authors:  Margaret A Honein; Suzanne M Gilboa; Cheryl S Broussard
Journal:  Expert Rev Clin Pharmacol       Date:  2013-08-24       Impact factor: 5.045

5.  Speech sound discrimination training improves auditory cortex responses in a rat model of autism.

Authors:  Crystal T Engineer; Tracy M Centanni; Kwok W Im; Michael P Kilgard
Journal:  Front Syst Neurosci       Date:  2014-08-05

6.  Modified hemispherectomy for infantile hemiparesis and epilepsy.

Authors:  Yu-Hui Li; Dong-Sheng Li; Mei-Qing Wang; Kai Zhao; Bu-Lang Gao
Journal:  Transl Neurosci       Date:  2020-10-20       Impact factor: 1.757

Review 7.  GABAergic signaling as therapeutic target for autism spectrum disorders.

Authors:  Giada Cellot; Enrico Cherubini
Journal:  Front Pediatr       Date:  2014-07-08       Impact factor: 3.418
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.